| |
 |
Dr. Qin-yong Dai, Ph.D
Medical Director, Department of Medical, Roche Hong Kong
Hong Kong, China |
|
| |
| Biography: |
|
| |
| Dr. Qinyong Dai graduated from medical school of Shanghai Jiao Tong University. He received medical training and clinical practice in Shanghai Ruijin hospital, followed by two years specialty training in bone marrow transplantation in Lyon, France Meanwhile, he also holds a Ph.D of experimental medicine in McGill University, Canada. |
| |
| In 2006, he joined GSK biological, China/ Hong Kong. Currently, he is the medical director of Roche Hong Kong, leading the medical affairs, clinical development and regulatory affairs. He has been working on clinical trials for over ten years with rich experience in different therapeutic areas. |
| |
| Session: |
|
| |
| 21st November 2015 (Saturday) |
 |
15:40 - 16:00 |
|
| |
| Session IV: Drug Development in the Pharmaceutical Industry |
| From Precise Diagnosis to More Personalized Therapy |
| |
| |
| |
| |
| |
|
|
